Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
RODEOHOUSTON Takes Over New York City’s Times Square: Surprise Pop-Up Concert Reveals Russell Dickerson as Entertainer in 2026 Lineup
-
Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio
-
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
-
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Richardson Electronics Reports Second Quarter Results; Declares Quarterly Cash Dividend
-
Asure Software Appoints Mike Eralie as Senior Vice President of Operations
-
Photronics Appoints Michelle Almeida to the Board of Directors
-
Grayscale Investments® Announces Rebalancing of Multi-Asset Funds for Fourth Quarter 2025
-
Costco Wholesale Corporation Reports December Sales Results
-
Healthcare Realty Announces Chief Financial Officer Transition
-
Live Oak Bancshares, Inc. Announces Date of Fourth Quarter 2025 Financial Results
-
Compass Diversified Announces Third Quarter and Year-to-Date 2025 Earnings and Conference Call Information
-
LanzaTech Achieves Guaranteed Performance at Japan MSW-to-Ethanol Plant
-
SAMstream Launches AI Platform to Help Organizations of All Sizes Find and Bid on Government Contracts
-
CMB.TECH FLEET UPDATE
-
BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes
-
Abivax Provides 2026 Corporate Outlook
-
iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation
-
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Kura Sushi USA Announces Fiscal First Quarter 2026 Financial Results
-
LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation
-
Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis
-
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Saratoga Investment Corp. Announces Fiscal Third Quarter 2026 Financial Results
-
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
-
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference
-
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution
-
Terrestrial Energy to Participate in the 28th Annual Needham Growth Conference
-
Twelve Seas Investment Company III Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 9, 2026
-
Constellation Brands Reports Third Quarter Fiscal 2026 Financial Results
-
Bitfarms to Present at Needham Growth Conference in NYC
-
RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Definitive Healthcare to Present at the 28th Annual Needham Growth Conference
-
Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Crane NXT to Participate in the CJS Securities 26th Annual New Ideas for the New Year Conference
-
Ethan Allen Announces Release Date for its Fiscal 2026 Second Quarter Results
-
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
-
Diamondback Energy, Inc. Schedules Fourth Quarter 2025 Conference Call for February 24, 2026
-
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules Fourth Quarter 2025 Conference Call for February 24, 2026
-
Genelux Corporation Announces Proposed Public Offering of Common Stock
-
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Art Technology Acquisition Corp. Announces the Closing of $220 Million Initial Public Offering
-
Crane Harbor Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 12, 2026
-
Republic Power Group Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq
-
Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
-
Amlan International Brings Gut Health and Feed Efficiency Innovation to IPPE 2026
-
Pure Cycle Announces Financial Results for the Three Months Ended November 30, 2025
-
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
